EH
Elaine J Heron
Director

Elaine J Heron insider trades: Palvella Therapeutics (PVLA) stock buys and sales

Director, Palvella Therapeutics Last trade Feb 27, 2026 47 Form 4 filings
$0
Sold, last 12 months
0 sales
$316K
Bought, last 12 months
2 buys
10
Open-market trades
since 2008
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Elaine reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 27, 2026PVLA↑ Buy$300K
Nov 17, 2025VXRT↑ Buy$16K
Sep 5, 2018BMRN↓ Sell$97K
Dec 14, 2017BMRN↓ Sell$71K
Nov 12, 2012BMRN↓ Sell$91K
Nov 9, 2012BMRN↓ Sell$6.3M
Mar 6, 2008BMRN↓ Sell$627K
Mar 6, 2008BMRN↓ Sell$374K
Mar 6, 2008BMRN↓ Sell$139K
Mar 3, 2008BMRN↓ Sell$769K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PVLA insiders

Open-market trades in the last 12 months

About Elaine J Heron's insider trades

Elaine J Heron is a director at Palvella Therapeutics (PVLA). Since Mar 3, 2008, Elaine has reported 2 open-market purchases worth $316K and 8 sales worth $8.5M on SEC Form 4. In the last 12 months: 2 buys ($316K).

Their filings also include grants and awards (30 filings), option exercises (9 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PVLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.